These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 30402660

  • 1. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.
    Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):617-624. PubMed ID: 30402660
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 Dec; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.
    Ishihara S, Gayat E, Sato N, Arrigo M, Laribi S, Legrand M, Placido R, Manivet P, Cohen-Solal A, Abraham WT, Jessup M, Mebazaa A.
    Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
    Ng TM.
    Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
    [Abstract] [Full Text] [Related]

  • 9. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
    Parissis JT, Andreadou I, Bistola V, Paraskevaidis I, Filippatos G, Kremastinos DT.
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

  • 12. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
    Heringlake M, Alvarez J, Bettex D, Bouchez S, Fruhwald S, Girardis M, Grossini E, Guarracino F, Herpain A, Toller W, Tritapepe L, Pollesello P.
    Expert Rev Cardiovasc Ther; 2021 Apr; 19(4):325-335. PubMed ID: 33739204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper.
    Herpain A, Bouchez S, Girardis M, Guarracino F, Knotzer J, Levy B, Liebregts T, Pollesello P, Ricksten SE, Riha H, Rudiger A, Sangalli F.
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):3-14. PubMed ID: 30489437
    [Abstract] [Full Text] [Related]

  • 15. Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system.
    Antoniades C, Antonopoulos AS, Tousoulis D, Bakogiannis C, Stefanadi E, Stefanadis C.
    Curr Drug Metab; 2009 Feb; 10(2):95-103. PubMed ID: 19275545
    [Abstract] [Full Text] [Related]

  • 16. Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
    Lannemyr L, Ricksten SE, Rundqvist B, Andersson B, Bartfay SE, Ljungman C, Dahlberg P, Bergh N, Hjalmarsson C, Gilljam T, Bollano E, Karason K.
    J Am Heart Assoc; 2018 Aug 21; 7(16):e008455. PubMed ID: 30369310
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan in the treatment of patients with acute cardiac conditions: an expert opinion of the Association of Intensive Cardiac Care of the Polish Cardiac Society.
    Tycińska A, Gierlotka M, Bugajski J, Deja M, Depukat R, Gruchała M, Grześk G, Kasprzak JD, Kubica J, Kucewicz-Czech E, Leszek P, Płonka J, Sobkowicz B, Straburzyńska-Migaj E, Wilk K, Zawiślak B, Zymliński R, Stępińska J.
    Kardiol Pol; 2020 Aug 25; 78(7-8):825-834. PubMed ID: 32788567
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levosimendan: a new era for inodilator therapy for heart failure?
    Cleland JG, McGowan J.
    Curr Opin Cardiol; 2002 May 25; 17(3):257-65. PubMed ID: 12015475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.